IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Silexion Therapeutics Corp

CUSIP: G1281K122 | 9 institutional holders

Quarters

Q2 2025Q1 2025Q4 2024
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2025

Wildcat Capital Management, LLC113,428
0.1% of portfolio›$91.9K
UBS Group AG109,257
0.0% of portfolio›$88.5K
Meyer Handelman Co32,967
0.0% of portfolio›$26.7K
Virtu Financial LLC14,264
0.0% of portfolio›$12
StoneX Group Inc.11,241
0.0% of portfolio›$9.1K
Bank of America Corp500
0.0% of portfolio›$405
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Wildcat Capital Management, LLC
113,428$91.9K0.1%GARPVery LowNew York, NY2025-07-18
UBS Group AG
109,257$88.5K0.0%CoreMediumZurich, Switzerland2025-08-14
Meyer Handelman Co
32,967$26.7K0.0%CoreLowRye Brook, NY2025-07-16
Virtu Financial LLC
14,264$120.0%GARPVery HighNew York, NY2025-08-12
StoneX Group Inc.
11,241$9.1K0.0%ETFMediumNew York, NY2025-08-13
Bank of America Corp
500$4050.0%CoreLowCharlotte, NC2025-08-14
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2025-08-12